• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用负载细胞因子的透明质酸基水凝胶处理的组织中引发的微血管成熟。

Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels.

作者信息

Hosack Luke W, Firpo Matthew A, Scott J Anna, Prestwich Glenn D, Peattie Robert A

机构信息

Department of Chemical Engineering, Oregon State University, 102 Gleeson Hall, Corvallis, OR 97331-2702, United States.

出版信息

Biomaterials. 2008 May;29(15):2336-47. doi: 10.1016/j.biomaterials.2008.01.033. Epub 2008 Mar 3.

DOI:10.1016/j.biomaterials.2008.01.033
PMID:18313745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2387277/
Abstract

Hydrogels composed of crosslinked, chemically modified hyaluronic acid (HA), gelatin (Gtn) and heparin (Hp) were preloaded with vascular endothelial growth factor (VEGF), angiopoietin-1 (Ang-1), keratinocyte growth factor (KGF) or platelet derived growth factor (PDGF) either individually or in combination with VEGF and implanted into the Balb/c mouse ear pinna. At 7 and 14 days post-surgery, elicited vascular maturity levels were quantified using immunohistochemical (IHC) staining techniques and reported as a vascular maturity index (VMI). At both time points, it was discovered that the dual cytokine combinations elicited greater maturity levels than that of cytokine administered individually. For example, VEGF and KGF-containing HA:Hp implants at day 7 yielded VMI values of -0.1375 and -0.092, respectively, whereas their combination resulted in a VMI of 0.176 (p<0.007). At day 7, only one of the seven HA:Hp experimental cases yielded a positive VMI (VEGF+KGF), whereas four of the seven HA:Hp cases yielded positive VMI values at day 14, indicating a sustained maturity response. The same general trends were found to exist in tissue treated with HA:Hp:Gtn experimental implants. Differences in elicited maturity also existed between tissue treated with HA:Hp and HA-containing hydrogels (VMI=0.176 for HA:Hp-VEGF+KGF vs. -0.064 for HA-VEGF+KGF, p<0.012), and these differences are thought to result from differences in characteristic cytokine release rates. This result also suggests that the presentation of multiple growth factors (GFs) on immobilized Hp may actively contribute to cytokine related signal transduction, a characteristic that may be exploited in the future to improve the efficacy of cytokine-loaded implants towards tissue regeneration therapeutic strategies.

摘要

由交联的、化学修饰的透明质酸(HA)、明胶(Gtn)和肝素(Hp)组成的水凝胶预先加载了血管内皮生长因子(VEGF)、血管生成素-1(Ang-1)、角质形成细胞生长因子(KGF)或血小板衍生生长因子(PDGF),这些因子可以单独加载,也可以与VEGF联合加载,然后植入Balb/c小鼠耳廓。在手术后7天和14天,使用免疫组织化学(IHC)染色技术对引发的血管成熟水平进行量化,并报告为血管成熟指数(VMI)。在两个时间点均发现,与单独施用细胞因子相比,双重细胞因子组合引发的成熟水平更高。例如,含VEGF和KGF的HA:Hp植入物在第7天的VMI值分别为-0.1375和-0.092,而它们的组合产生的VMI为0.176(p<0.007)。在第7天,七个HA:Hp实验案例中只有一个产生了正的VMI(VEGF+KGF),而在第14天,七个HA:Hp案例中有四个产生了正的VMI值,表明存在持续的成熟反应。在使用HA:Hp:Gtn实验植入物处理的组织中也发现了相同的总体趋势。用HA:Hp处理的组织与含HA的水凝胶处理的组织之间在引发的成熟度上也存在差异(HA:Hp-VEGF+KGF的VMI=0.176,而HA-VEGF+KGF的VMI=-0.064,p<0.012),这些差异被认为是由特征性细胞因子释放速率的差异导致的。该结果还表明,固定化Hp上多种生长因子(GFs)的呈现可能积极促进细胞因子相关的信号转导,这一特性未来可能会被利用来提高负载细胞因子的植入物对组织再生治疗策略的疗效。

相似文献

1
Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels.用负载细胞因子的透明质酸基水凝胶处理的组织中引发的微血管成熟。
Biomaterials. 2008 May;29(15):2336-47. doi: 10.1016/j.biomaterials.2008.01.033. Epub 2008 Mar 3.
2
Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels.原位交联、双重生长因子负载的糖胺聚糖水凝胶促进体内血管生成。
Biomaterials. 2010 Jun;31(17):4630-8. doi: 10.1016/j.biomaterials.2010.02.043. Epub 2010 Mar 15.
3
Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.肝素调节生长因子的体外释放以及体内对植入含血管内皮生长因子(VEGF)和碱性成纤维细胞生长因子(bFGF)的透明质酸水凝胶的血管生成反应。
Biomaterials. 2006 Oct;27(30):5242-51. doi: 10.1016/j.biomaterials.2006.05.018. Epub 2006 Jun 30.
4
Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants.使用透明质酸水凝胶植入物在体内进行双生长因子诱导的血管生成。
Biomaterials. 2006 Mar;27(9):1868-75. doi: 10.1016/j.biomaterials.2005.09.035. Epub 2005 Oct 21.
5
Effect of gelatin on heparin regulation of cytokine release from hyaluronan-based hydrogels.明胶对肝素调节基于透明质酸水凝胶中细胞因子释放的影响。
Drug Deliv. 2008 Aug;15(6):389-97. doi: 10.1080/10717540802035442.
6
Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels.使用负载双生长因子的交联糖胺聚糖水凝胶刺激体内血管生成。
Biomaterials. 2006 Dec;27(35):5935-43. doi: 10.1016/j.biomaterials.2006.08.029. Epub 2006 Sep 6.
7
Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants.细胞因子负载透明质酸水凝胶植入物对体内血管生成的刺激作用。
Biomaterials. 2004 Jun;25(14):2789-98. doi: 10.1016/j.biomaterials.2003.09.054.
8
Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis.具有持续释放血管内皮生长因子以诱导血管生成的可注射明胶衍生物水凝胶。
Acta Biomater. 2015 Feb;13:88-100. doi: 10.1016/j.actbio.2014.11.002. Epub 2014 Nov 8.
9
A cocktail of growth factors released from a heparin hyaluronic-acid hydrogel promotes the myogenic potential of human urine-derived stem cells in vivo.从肝素透明质酸水凝胶中释放的生长因子鸡尾酒在体内促进了人尿源性干细胞的成肌潜能。
Acta Biomater. 2020 Apr 15;107:50-64. doi: 10.1016/j.actbio.2020.02.005. Epub 2020 Feb 8.
10
Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels.明胶水凝胶中富含血小板的血浆内容物和碱性成纤维细胞生长因子的多次释放促进血管生成。
Acta Biomater. 2012 May;8(5):1792-801. doi: 10.1016/j.actbio.2012.01.016. Epub 2012 Jan 21.

引用本文的文献

1
Gelatin as It Is: History and Modernity.明胶原貌:历史与现代性
Int J Mol Sci. 2023 Feb 10;24(4):3583. doi: 10.3390/ijms24043583.
2
Hydrogel vehicles for sequential delivery of protein drugs to promote vascular regeneration.水凝胶载体用于序贯递呈蛋白类药物促进血管再生。
Adv Drug Deliv Rev. 2019 Sep-Oct;149-150:95-106. doi: 10.1016/j.addr.2019.08.005. Epub 2019 Aug 14.
3
Extended release formulations using silk proteins for controlled delivery of therapeutics.采用丝蛋白的控释制剂用于治疗药物的控释。

本文引用的文献

1
Effect of gelatin on heparin regulation of cytokine release from hyaluronan-based hydrogels.明胶对肝素调节基于透明质酸水凝胶中细胞因子释放的影响。
Drug Deliv. 2008 Aug;15(6):389-97. doi: 10.1080/10717540802035442.
2
The roles of hypoxia in the in vitro engineering of tissues.缺氧在组织体外工程中的作用。
Tissue Eng. 2007 Sep;13(9):2153-62. doi: 10.1089/ten.2006.0417.
3
Simplifying the extracellular matrix for 3-D cell culture and tissue engineering: a pragmatic approach.简化用于三维细胞培养和组织工程的细胞外基质:一种实用方法。
Expert Opin Drug Deliv. 2019 Jul;16(7):741-756. doi: 10.1080/17425247.2019.1635116. Epub 2019 Jul 1.
4
Native-mimicking in vitro microenvironment: an elusive and seductive future for tumor modeling and tissue engineering.模拟天然的体外微环境:肿瘤建模与组织工程领域一个难以捉摸却又极具吸引力的未来。
J Biol Eng. 2018 Sep 12;12:20. doi: 10.1186/s13036-018-0114-7. eCollection 2018.
5
Auxiliary Biomembranes as a Directional Delivery System To Control Biological Events in Cell-Laden Tissue-Engineering Scaffolds.辅助生物膜作为一种定向递送系统,用于控制载有细胞的组织工程支架中的生物学事件。
ACS Omega. 2017 Mar 31;2(3):918-929. doi: 10.1021/acsomega.6b00502. Epub 2017 Mar 15.
6
Treatment of limb wounds of horses with orf virus IL-10 and VEGF-E accelerates resolution of exuberant granulation tissue, but does not prevent its development.用羊口疮病毒 IL-10 和 VEGF-E 治疗马的肢体伤口可加速过度肉芽组织的消退,但不能预防其发生。
PLoS One. 2018 May 15;13(5):e0197223. doi: 10.1371/journal.pone.0197223. eCollection 2018.
7
New Delivery Systems of Stem Cells for Vascular Regeneration in Ischemia.用于缺血性血管再生的干细胞新型递送系统
Front Cardiovasc Med. 2017 Feb 24;4:7. doi: 10.3389/fcvm.2017.00007. eCollection 2017.
8
A tunable hydrogel system for long-term release of cell-secreted cytokines and bioprinted in situ wound cell delivery.一种可调节水凝胶系统,用于细胞分泌细胞因子的长期释放,并可原位生物打印输送伤口细胞。
J Biomed Mater Res B Appl Biomater. 2017 Oct;105(7):1986-2000. doi: 10.1002/jbm.b.33736. Epub 2016 Jun 28.
9
Depot-Based Delivery Systems for Pro-Angiogenic Peptides: A Review.基于储存库的促血管生成肽递药系统:综述。
Front Bioeng Biotechnol. 2015 Jul 16;3:102. doi: 10.3389/fbioe.2015.00102. eCollection 2015.
10
Modular and orthogonal synthesis of hybrid polymers and networks.杂化聚合物和网络的模块化与正交合成。
Chem Commun (Camb). 2015 Mar 28;51(25):5218-37. doi: 10.1039/c4cc09568e.
J Cell Biochem. 2007 Aug 15;101(6):1370-83. doi: 10.1002/jcb.21386.
4
Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth.血管生成素-2的全身过表达促进肿瘤微血管消退并抑制血管生成和肿瘤生长。
Cancer Res. 2007 Apr 15;67(8):3835-44. doi: 10.1158/0008-5472.CAN-06-4056.
5
Release of basic fibroblast growth factor from a crosslinked glycosaminoglycan hydrogel promotes wound healing.从交联糖胺聚糖水凝胶中释放碱性成纤维细胞生长因子可促进伤口愈合。
Wound Repair Regen. 2007 Mar-Apr;15(2):245-51. doi: 10.1111/j.1524-475X.2007.00211.x.
6
Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways.透明质酸介导的血管生成在血管疾病中的作用:揭示RHAMM和CD44受体信号通路
Matrix Biol. 2007 Jan;26(1):58-68. doi: 10.1016/j.matbio.2006.08.261. Epub 2006 Sep 19.
7
Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels.使用负载双生长因子的交联糖胺聚糖水凝胶刺激体内血管生成。
Biomaterials. 2006 Dec;27(35):5935-43. doi: 10.1016/j.biomaterials.2006.08.029. Epub 2006 Sep 6.
8
Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering.用于组织工程的可注射原位交联合成细胞外基质的合成与评价
J Biomed Mater Res A. 2006 Dec 15;79(4):902-12. doi: 10.1002/jbm.a.30831.
9
Vascularity and angiogenesis as predictors of growth in optic pathway/hypothalamic gliomas.血管形成及血管生成作为视路/下丘脑胶质瘤生长的预测指标
J Neurosurg. 2006 May;104(5 Suppl):314-20. doi: 10.3171/ped.2006.104.5.314.
10
Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.肝素调节生长因子的体外释放以及体内对植入含血管内皮生长因子(VEGF)和碱性成纤维细胞生长因子(bFGF)的透明质酸水凝胶的血管生成反应。
Biomaterials. 2006 Oct;27(30):5242-51. doi: 10.1016/j.biomaterials.2006.05.018. Epub 2006 Jun 30.